{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-008781","form_type":"8-K","ticker":"NUWE","cik":"0001506492","company_name":"Nuwellis, Inc.","filed_at":"2026-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.262467+00:00","generated_at":"2026-05-15T16:23:53.259218+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nuwellis Q4 revenue +4% to $2.4M; full year -5%; acquires Rendiatech","bullets":["Q4 2025 revenue $2.4M (+4% YoY, +9% sequential); gross margin 68.2% vs 58.4% prior year.","Full year 2025 revenue $8.3M (-5% YoY); net loss $17.5M includes $6.4M non-cash warrant expense.","U.S. console sales up 208% YoY in Q4 (8 vs 3 units); Heart Failure +48%, Pediatrics +16%.","Closed $5.0M private placement and warrant inducement in Jan 2026; appointed Carisa Schultz CFO Feb 2, 2026.","Executed definitive stock purchase agreement to acquire Rendiatech; no financial terms disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-008781","json":"https://secwatch.observer/filing/0001140361-26-008781.json","markdown":"https://secwatch.observer/filing/0001140361-26-008781.md","text":"https://secwatch.observer/filing/0001140361-26-008781.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506492/000114036126008781/0001140361-26-008781-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506492/000114036126008781/ef20067396_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T16:23:53.259218+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"266f9b12766cdba19048006606dd154c733912cf","claim":"Nuwellis, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $2.4 million, net income approximately $2.4 million.","evidence_excerpt":"conditions, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Recent Highlights: • Fourth quarter revenue of $2.4 million, a 4% increase compared to the prior-year quarter and 9% increase sequentially. • 208% increase in U.S. console sales in Q4 versus prior year quarter. • Heart Failure revenue","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1506492/000114036126008781/0001140361-26-008781-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2025"},{"label":"Revenue","value":"$2.4 million"},{"label":"Net income","value":"approximately $2.4 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"2f205bcf04071c171dd15cc79e677079670a32dd","claim":"Nuwellis, Inc. reported the full year ended December 31, 2025 results: revenue $8.3 million, net income $17.5 million.","evidence_excerpt":"Revenue for the full year ended December 31, 2025, was $8.3 million, a 5% decrease compared to the prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1506492/000114036126008781/0001140361-26-008781-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2025"},{"label":"Revenue","value":"$8.3 million"},{"label":"Net income","value":"$17.5 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}